Neuroprotective agents : clinical and experimental aspects

This volume describes the use of both short- and long-term treatment of such neuroprotective agents as calcium channel antagonists, adenosine, cannabinoids, and NMDA receptor antagonists in cerebral ischaemia, hypoxia, head trauma, and neurotrauma, among other pathologic conditions. Further study is made of reactive oxygen species in neuronal degeneration and free radical mechanisms and neuroprotective antioxidants.